Industry & Policy News

[Dispatch Bio] Dispatch Bio announced the first participant has been dosed in a Phase I clinical trial evaluating the safety and efficacy of DISP-10 in adult participants with advanced gastrointestinal (GI) cancers,

[AcroCyte Therapeutics, Inc.] AcroCyte Therapeutics, Inc. announced that it has been selected to receive funding from the Advanced Research Projects Agency for Health (ARPA‑H) to advance scalable human organoid technologies for regenerative medicine applications.

[BCRF ] The Breast Cancer Research Foundation (BCRF) announced a $1.5 million grant over five years to support Team ATLAS, an international research collaboration exploring why some people remain breast cancer-free despite age, inherited risk, environmental exposures, or other known risk factors.

[University of Auckland] Seven research projects offering innovative ideas to achieve better outcomes for a range of health issues including breast cancer, HIV transmission and autoimmune disease have been awarded a total of just over $1 million in the Health Research Council's Explorer grant.

[The Den] Mercer University School of Medicine has been awarded the fifth annual Collaborative Cancer Research Seed Grant of $100,000 to advance research aimed at improving treatment for one of the most aggressive forms of endometrial cancer. This grant will support a research project led by Dr. Ilana Chefetz Menaker.

[Queen's Gazette] 13 research teams at Queen’s University have received a combined $12.7 million from the Canadian Institutes of Health Research (CIHR). Awarded through CIHR's Project Grant: Spring 2026 competition, each project will work towards advancing the wellbeing of Canadians through translational research.